Please login to the form below
ISPE looks to Boehringer for new VP of Europe
Thomas Zimmer was senior VP at German pharma company
Thomas Zimmer has left his senior VP role at Boehringer Ingelheim to join the International Society for Pharmaceutical Engineering (ISPE) as VP of European operations.
In his new role, Zimmer will be responsible for leading ISPE's business development and advancing strategic relationships in Europe.
He spent 32 years at German pharma company Boehringer, serving in senior roles across development, production, quality and supply chain management
In addition, Zimmer has experience at the European Federations of Pharmaceutical Industry Associations (EFPIA) and as a member of the World Health Organization's (WHO) IMPACT taskforce.
"Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large," said ISPE President and CEO Nancy Berg.
"Thomas's first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world."
Subscribe to our email news alerts
- Planting the Seeds for Future Women Leaders in Medicine
- FDA approves SpringWork’s Ogsiveo as first therapy for desmoid tumours
- GSK shares positive phase 3 results for Blenrep combination in multiple myeloma
- Stem cell therapy trial shows promising results for treating progressive MS
- Cancer Research UK calls on government to create ten-year cancer plan
- Risk calculator to prevent heart attacks and strokes in type 2 diabetes patients
No results were found
PMHub
Red Thread Market Access Ltd
Blending brilliant writing with in-depth market access and reimbursement expertise...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
